Cosmeceutical skincare brand iS Clinical has introduced a new suncare product, the Extreme Protect SPF30.
A new drug has been developed that aims to mimic sunlight and cause the skin to tan without the damaging effects of UV radiation.
A recent study held by consumer product review company Which? suggests that water-resistant sunscreens lose their efficacy after coming into contact with salt water, chlorinated water and fast-moving water.
Sunscreens containing oxybenzone and octinoxate may soon be prohibited in Hawaii.
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.
A new study examining associations between indoor tanning and melanoma has suggested a melanoma diagnosis is more common in younger women.
A study published by the Journal of Investigative Dermatology has revealed promising results for a new vaccine that could prevent acne vulgaris.
According to a study published in Nature journal, researchers in Australia have discovered two rare forms of melanoma that are not caused by sun exposure unlike the cutaneous melanoma that is strongly linked to UV radiation.
A study conducted by Reichrath et al, and published in Anticancer Research, has suggested that there is no evidence to demonstrate a relationship between moderate solarium use and melanoma.
A US pilot study investigating the use of oral JAK1/2 inhibitor ruxolitinib in the treatment of patients with moderate to severe alopecia areata has indicated a 75% growth in scalp hair regrowth.